Strong Holiday Season Performance; Momentum Continuing into 2025Establishes 2025 Outlook; Expects Growth to Continue in Q1 2025 PLANO, Texas, March […]
Generative Phosphoproteomics AP3 platform designed to enable streamlined, rational drug discovery, with proprietary, proteome-wide SAR delivering desirable pathway effects R&D […]